Atlas Trials

Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients

Clinical trial NCT04300790 · COMPLETED

Trial details

NCT number
NCT04300790
Sponsor
MedSIR
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2020-10-23
Primary completion
2022-06-15
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.